References
Acang N., Jalil F. D., (1993). Hypercoagulation in diabetes mellitus. The Southeast Asian Journal of Tropical Medicine and Public Health. 24(Suppl 1):263–266. Agarwal C., Bansal K., Pujani M., Singh K., Chauhan V., Rana D, et al. (2019). Association of coagulation profile with microvascular complications and glycemic control in type 2 diabetes mellitus - a study at a tertiary care center in Delhi. HematolTransfus Cell Ther. 41(1):31-36. doi: 10.1016/j.htct.2018.05.002 Amrita K., Isha A., Shweta R., (2025). Impact of Type II Diabetes Mellitus on Prothrombin Time and Activated Partial Thromboplastin Time– A Systematic review and Meta – Analysis. International Journal of Life Sciences, Biotechnology and Pharma Research. 14(3):129-139 DOI: 10.69605/ijlbpr_14.3.2025.23 Ankalayya B., Sodhi H. S., Modala S., Baghel M.. (2016). A comparative study of coagulation time in type 2 diabetes mellitus and healthy individuals. International Journal of Contemporary Medical Research. 3(11):3170–3171. Asrat D., Tesfaye G., Gedefaw L., Addisu W., Yemane T., (2019). Hemostatic abnormality and associated factors in diabetic patients at Jimma UniversitySpecialized Hospital, Jimma, Southwest Ethiopia: a Comparative Cross-sectional Study. Ethiop J Health Sci. 29(2):251–258. doi:10.4314/ejhs.v29i2.12 Chavan P. S., Afroz S., Jadhav S., (2014). A comparative study of coagulation tests in type 2 diabetes mellitus individuals and health individuals. Int J Med Sci.3(1):290–298. Cheesbrough M., (2006). Investigation of bleeding disorders. District ¬Laboratory Practice in Tropical Countries. Cambridge, UK: Cambridge University Press. 341-347. Ebrahim H., Asrie F., Getaneh Z, (2021). Basic coagulation profiles and platelet parameters among adult type 1 and type 2 diabetes patients at Dessie Referral Hospital, Northeast Ethiopia: comparative cross-sectional study. J Blood Med. 12:33–42. doi:10.2147/JBM.S287136 Fan W., Song Y., Inzucchi S. E, et al. (2019). Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry. Diabetes ObesMetab. 21:1121-1112. DOI: 10.1111/dom.13625 Getu F., Aynalem M., Bizuneh S., Enawgaw B., (2022). The Prevalence of Coagulopathy and Associated Factors Among Adult Type II Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 15: 579–59 Ghongade P. V., Patil B. U., Shivkumar V. B., (2023). Correlation of glycated hemoglobin with coagulation profile and hematological parameters in type II diabetes mellitus. Chron Dis J. 11(1):38-46. doi: 10.22122/cdj.v11i1.702 Greer J.P., et al. (2003) Wintrobe’s clinical hematology. 11th Edition, Lippincott Williams & Wilkins, Philadelphia. Ifeanyi O. E., Chukwuemeka O. H., Sunday A. G., Uche E. C., (2014). Changes in some coagulation parameters among diabetic patients in Michael Okpara university of agriculture, Umudike, Abia state, Nigeria. World journal of pharmacy and pharmaceutical sciences. 3(4):52–61. Kottgen A., Russell S. D., Loehr L. R., et al. (2007). Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities Study. JASN. 18 (4) 1307-1315; DOI: 10.1681/ASN.2006101159 Kulkarni Y. L., Jadhav S. S., Lad U. P., Sable M., Ingole A., Nanaware N. (2023). A comparative study of coagulation profile of type 2 diabetic individuals with healthy individuals. Int J Acad Med PharmN. 5(4):1510-1513. doi: 10.47009/jamp.2023.5.4.300 Lippi G., Franchini M., Targher G., Montagnana M., Salvagno G., Guidi G., et al. (2009). Epidemiological association between fasting plasma glucose and shortened APTT. Clin Biochem. 42:118–120. doi: 10.1016/j.clinbiochem.2008.10.012 Madan R., Gupt B., Saluja S., Kansra U., Tripathi B., Guliani B., (2010). Coagulation profile in diabetes and its association with diabetic microvascular complications. Assoc Physicians India. 58:481–484. Mariappan A., Deepa V. S., Nagendran R. (2017). Evaluation of coagulation profile in type-1 diabetes mellitus patients: A hospital-based prospective study. Int J BiotechnolBiochem. 13(1):49-54. Ng V. L., (2009).Prothrombine time and partial thromboplastin time assay considerations. Clin Lab Med. 29:253–263. doi: 10.1016/j.cll.2009.05.002. Pan L., Ye Y., Wo M., et al. (2018). Clinical significance of hemostatic parameters in the prediction for type 2 diabetes mellitus and diabetic nephropathy. Dis Markers. 2018:2–3. doi:10.1155/2018/5214376 Sattar N., Rawshani A., Franzén S., et al. (2019). Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks. Findings From the Swedish National Diabetes Registry. Circulation. 7;139(19):2228-2237. DOI: 10.1161/CIRCULATIONAHA.118.037885 Shimizu H., (1998). Thrombocytopenia in insulin-dependent diabetes mellitus. Kitakanto Med J. 48(4):283–285. doi:10.2974/kmj.48.283. World Health Organization, IDF. (2006). Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation [Internet]. Geneva: World Health Organization. Available from: http://www.who.int/iris/handle/10665/43588 Yeung S. L. A., Luo S., Schooling M., (2018). The Impact of Glycated Hemoglobin (HbA1c) on Cardiovascular Disease Risk: A Mendelian Randomization Study Using UK Biobank. Diabetes Care. 41(9):1991-1997. DOI: 10.2337/dc18-0289 Zhao Y., Zhang J., Zhang J., Wu J., (2011). Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values. PLoS One. 6:1–4. doi: 10.1371/journal.pone.0016470.
